Patents
Oxidant scavengers patent may affect amyotrophic lateral sclerosis
Published in Health and Medicine Week, October 27th, 2003
Claims in the patent describe a method of treating diseases resulting from degradation of nitric oxide and accumulation of peroxynitrite by administration of a catalytic-antioxidant compound.
A prominent theory of amyotrophic lateral sclerosis (ALS) is that accumulation of peroxynitrite plays a causative role in the destruction of motor neurons.
"This patent confers additional new protection for our priority project of developing a drug for treatment of ALS," stated Richard E. Gammans, PhD, Incara's head of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Pneumococcus
New vaccine for children reduces severe infection from common bacteria - Water-borne Illness
Home-treated water no better than plain tap in preventing GI illness - Complementary and Alternative Medicine
Diets largely based on plant foods are viewed more as improving health - Drug Marketing
Curious and confused: Prescription drug ads impact consumer health - Ethics
Minority children: Over- or under-represented in medical research? - Injury Prevention
Report: Home visits can reduce child abuse, gun control may not lessen violence - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
